GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Ending Cash Position

Veru (STU:FMW) Ending Cash Position : €25.41 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Veru Ending Cash Position?

Veru's Ending Cash Position for the quarter that ended in Dec. 2024 was €25.41 Mil.

Veru's quarterly Ending Cash Position declined from Jun. 2024 (€27.08 Mil) to Sep. 2024 (€22.45 Mil) but then increased from Sep. 2024 (€22.45 Mil) to Dec. 2024 (€25.41 Mil).

Veru's annual Ending Cash Position declined from Sep. 2022 (€80.99 Mil) to Sep. 2023 (€9.02 Mil) but then increased from Sep. 2023 (€9.02 Mil) to Sep. 2024 (€22.45 Mil).

Veru Ending Cash Position Historical Data

The historical data trend for Veru's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Ending Cash Position Chart

Veru Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.54 104.01 80.99 9.02 22.45

Veru Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.21 31.96 27.08 22.45 25.41

Veru Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Veru's Ending Cash Position for the fiscal year that ended in Sep. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=8.671+13.778
=22.45

Veru's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=23.796+1.614
=25.41

Veru Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Veru's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Veru Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Ending Cash Position
Comparable Companies
IGMS EPIX IVVD AVTE TNYA ACOG UNCY MNOV TELO SAVA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
VERU:USA
Address
2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127
Website
https://www.verupharma.com
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Veru Headlines

No Headlines